CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 28, 2012	Sep. 30, 2011
Operating Activities
Net loss	$ (148.4)	$ (183.5)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	38.2	57.6
Loss on disposal of property, plant and equipment	1.1	0.7
Equity-based compensation	15.8	21.9
Deferred income taxes	0.3	(0.8)
Restructuring and other charges	110.2	20.5
Net (gain) loss on investments in marketable securities	(0.8)	0.1
Goodwill and IPR&D impairment		102.7
Other-than-temporary impairment charges on investments		1.8
Excess tax benefits from equity-based compensation		(0.2)
Net changes in assets and liabilities:
Accounts receivable	31.4	43.6
Inventories	41.2	6.8
Miscellaneous receivables and other current assets	14.8	(11.0)
Other assets	(0.4)	(2.5)
Accounts payable	(38.5)	(14.0)
Restructuring and other charges	(31.2)	(9.8)
Deferred revenue	(18.9)	(8.1)
Other accrued liabilities	(4.2)	(59.2)
Income taxes	(2.9)	3.4
Other long-term liabilities	(3.2)	(1.8)
Net Cash Provided by (Used for) Operating Activities	4.5	(31.8)
Investing Activities
Capital expenditures	(16.8)	(45.8)
Payments for purchases of investments	(401.6)	(616.1)
Proceeds from sales and maturities of investments	442.9	708.7
Net Cash Provided by Investing Activities	24.5	46.8
Financing Activities
Proceeds from short-term borrowings		1.3
Payments of short-term borrowings		(1.3)
Proceeds from issuance of common stock under stock plans	0.1	0.6
Repurchase of common stock	(3.7)	(5.0)
Excess tax benefits from equity-based compensation		0.2
Dividends paid	(22.0)	(21.8)
Net Cash Used for Financing Activities	(25.6)	(26.0)
Effect of Exchange Rate Changes on Cash	(1.2)	(3.6)
Net Increase (Decrease) in Cash and Cash Equivalents	2.2	(14.6)
Cash and Cash Equivalents - Beginning of Year	132.7	208.8
Cash and Cash Equivalents - End of Period	$ 134.9	$ 194.2